Conference Day 2

Day Two

Wednesday December 7, 2022

7:30 am Networking

8:30 am Chair’s Welcome

8:30 am Discover: Zero Carbon Leadership in Labs: Building a Global Culture of Sustainability in Science


  • Learn about the surprising carbon impact of life science and key leverage points for
  • Discover how My Green Lab’s programs can be a core part of a Life Science Company’s
    ESG strategy
  • Gain practical insight from case studies of Green Lab Programs from some of the
    world’s leading Life Science companies

Harnessing Sustainable Solutions to Reduce Your Organization’s Internal Footprint

9:00 am Discover: Optimizing Facility Energy Management to Cut Energy Waste to Earn Green Certifications

  • Nicole Kho Director, Sustainability, Gilead Sciences


  • Realizing energy efficient facility design to optimize energy savings across sites to forge international internal standards
  • Reviewing capacity usage and other data to reduce the servicing equipment used and minimize greenhouse gas emissions
  • How Gilead Sciences integrated energy efficient design to make annual energy 4,100 MWh and 188,000 therms to earn Green Certifications

9:20 am Discover: Building a Culture of Green & Sustainable Science to Reduce Environmental Impact

  • Jack Gavin Director, Environmental Sustainability, Merck


  • Integrating Green & Sustainable Science into process research & development
  • Working across the industry to collaborate on the development of green metrics and tools
  • How Merck is consistently driving innovation by setting high internal expectations – and getting recognized for it

9:40 am Develop: How Will You Strive to Improve Sustainability Practices Within An Organization?


Question & Answer Session Facilitated by the Chair

10:00 am Action: Which Sustainable Practice Approaches Will You Take Into Your Organization to Improve Internal Sustainability?


Output Focused Action Session Facilitated by the Chair

10:20 am Refreshment & Networking Break

Driving Best Diversity Practices in the Workplace & Investigative Environments

10:50 am Panel Discussion: Reimagining DE&I Strategies in Life Science Organizations to Deliver for Your Specific Employee Goals & Satisfy ESG Stakeholders

  • Janine Ting Jansen Global Diversity Equity Inclusion & Belonging Lead, Organon Pharmaceuticals
  • Adriana Zupa-Fernandez Global Director Sustainability Strategy, Engagement & Culture , Bristol Myers Squibb


  • How to elevate underrepresented groups into high seniorities to improve diversity of in senior positions
  • Incorporating both employee opinions and data into DE&I strategy to deliver on community-specific DE&I issues
  • Providing examples of incorporated DE&I effectively into daily practices and reportable ESG outcomes

11:10 am Discover: Building Diversity, Inclusion and Belonging (DIB) Into the Fabric of your Company


  • How a more humanistic, caring, “bottom up” approach to building culture can imbed and amplify diversity, inclusion and belonging in your organization
  • How small to mid-size organizations can tackle DIB with creative, targeted approaches with minimal resources but big impact
  • How Be Bio is using an innovative community-wide mentorship programs to transform how senior leaders engage and progress underrepresented groups to senior positions in the industry

11:30 am Discover: Integrating Strong ESG Frameworks & Standards Into Clinical Trial Development

  • Wendy Erler Vice President & Global Head of Patient Experience, Alexion, Astra Zeneca Rare Disease


  • Assessing clinical trial evolution from an ESG lens
  • Gathering insights from across patient and investigator perspectives to ensure ESG in clinical trials
  • Explaining lessons learned to maximize ESG success in future clinical trials

11:50 am Develop: Digging Deep into Best Diversity Practices to Invigorating a Representative Employee & Patient Base

  • Brad Hartman Chief People Officer, Be Biopharma
  • Wendy Erler Vice President & Global Head of Patient Experience, Alexion, Astra Zeneca Rare Disease
  • Janine Ting Jansen Global Diversity Equity Inclusion & Belonging Lead, Organon Pharmaceuticals

12:10 pm Action: Roundtable: Overcoming Barriers to Diversity, Equity & Inclusion in the Workforce


  • What are the barriers to clinical trial enrollment for underrepresented populations (including, but not limited to, ethnicity, race, age, disability and geography)?
  • What are the barriers for companies in terms of enrolling underrepresented populations? Do these differ based on size of company? Size of indication?
  • What innovative strategies have been effective to increase clinical trial enrollment for underrepresented populations?

12:30 pm Lunch & Networking

1:30 pm Speed Learning


In this quick fire session, each table will be hosted by an ESG leader who will share the secrets of their
most high-impact leap; you then get the opportunity to question the host before moving on to your
next table.

Embedding Environmental Sustainability into the DNA of an organization: Employee Engagement

Assembling a Functional ESG Team When There is No “Dedicated” ESG Lead To Coordinate Effective ESG Planning

  • Mandy Fahey Executive Director, Corporate Communications, Insmed Inc.

Working Effectively with PR Agencies to Deliver Strong ESG Messages to Different Stakeholders

2:30 pm Chair’s Closing Remarks & Close of Conference